Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-01-10
2006-01-10
Stockton, Laura L. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S316000, C514S338000, C514S318000, C514S253010, C514S255010, C514S237500, C514S238800, C514S235500, C514S236800, C514S269000, C514S211080, C540S575000, C544S369000, C544S133000, C544S333000, C544S124000, C544S364000, C546S270400, C546S193000, C546S187000, C548S181000
Reexamination Certificate
active
06984652
ABSTRACT:
Compounds comprising an indazolyl group and a thiazolyl group, preferably 7-substituted 3-(thiazol-2-yl)-1H-indazole compounds in which the indazolyl group and a thiazolyl group are each independently optionally substituted, are useful for the treatment or prophylaxis of bacterial infections in mammals. The compounds are believed to function by inhibiting gyrase B.
REFERENCES:
patent: 3995044 (1976-11-01), Kabbe et al.
patent: 4909827 (1990-03-01), Gehring et al.
patent: 5140034 (1992-08-01), Baker et al.
patent: 5174808 (1992-12-01), Wroblowsky et al.
patent: 5208248 (1993-05-01), Baker et al.
patent: 5569669 (1996-10-01), Guillaumet et al.
patent: 6077954 (2000-06-01), Cook et al.
patent: 6166027 (2000-12-01), Straub et al.
patent: 6391872 (2002-05-01), Marfat
patent: 6451805 (2002-09-01), Straub et al.
patent: 6455525 (2002-09-01), Singh et al.
patent: 6555539 (2003-04-01), Reich et al.
patent: 6608087 (2003-08-01), Badia et al.
patent: 6716978 (2004-04-01), Marfat
patent: 2002/0058687 (2002-05-01), Marfat
patent: 2002/0099208 (2002-07-01), Yu et al.
patent: 2003/0119868 (2003-06-01), Badia et al.
patent: 2003/0171403 (2003-09-01), Garthwaite et al.
patent: 2003/0187026 (2003-10-01), Li et al.
patent: 2003/0199511 (2003-10-01), Li et al.
patent: 2004/0087642 (2004-05-01), Zeldis et al.
patent: 2004/0092568 (2004-05-01), Zeldis
patent: 2004/0110815 (2004-06-01), Cournoyer et al.
patent: 1040829 (2000-10-01), None
patent: 1346982 (2003-09-01), None
patent: 01380576 (2004-01-01), None
patent: 02007066 (1990-01-01), None
patent: 03206042 (1991-09-01), None
patent: 2003231687 (2003-08-01), None
patent: WO 92/12149 (1992-07-01), None
patent: WO 93/02677 (1993-02-01), None
patent: WO99/23076 (1999-05-01), None
patent: WO99/23077 (1999-05-01), None
patent: WO01/57024 (2001-08-01), None
patent: WO03/024397 (2003-03-01), None
patent: WO03/035625 (2003-05-01), None
patent: WO 2003/051366 (2003-06-01), None
patent: WO03/068754 (2003-08-01), None
patent: WO 2003/101968 (2003-12-01), None
patent: WO2004/060318 (2004-07-01), None
patent: WO2004/087699 (2004-10-01), None
patent: WO2004/094388 (2004-11-01), None
Shafiee A. et al., “Syntheses, Antibacterial and Antifungal Activities of Substituted-Thiazolo-1, 3, 4-thiadiazoles, 1, 3, 4-oxadiazoles and 1, 2, 4-triazoles,” Iranian Journal of Chemistry and Chemical Engineering. Cultural Division of Jihad Daneshgahi, Tehran, IR, vol. 17, No. 1, 1998, pp. 14-20.
International Search Report and Written Opinion for Application No. PCT/US2004/019174 dated Oct. 26, 2004.
Soos, T. et al.; “Novel Thermal Rearrangement of Fused Diaryl-v-Triazolium Salts to Neutral Indazole Derivatives. Fused Azolium Salts. 16.;” Journal of Organic Chemistry (1977), 62(4), 1136-1138.
Appelt Krzysztof
Chu Shaosong
Li Xiaoming
Yager Kraig
Ashbrook Charles W.
Dixon J. Michael
Stockton Laura L.
Warner-Lambert Company LLC
LandOfFree
Gyrase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gyrase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gyrase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3596625